Your shopping cart is currently empty

IXA62 is an orally active, selective IRE1/XBP1s agonist (EC50= 0.31 μM) that can reduce Aβ secretion.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | 10-14 weeks | 10-14 weeks | |
| 50 mg | Inquiry | 10-14 weeks | 10-14 weeks |
| Description | IXA62 is an orally active, selective IRE1/XBP1s agonist (EC50= 0.31 μM) that can reduce Aβ secretion. |
| In vitro | IXA62 is a selective activator of IRE1/XBP1s that reduces Aβ secretion in CHO 7PA2 cells and enhances glucose-stimulated insulin secretion in rat insulinoma cells, demonstrating effects similar to IXA4 in these experiments. |
| In vivo | IXA62 (orally or i.p, 50 mg/kg) robustly and selectively activates the IRE1/XBP1s signaling pathway in the liver of mice. |
| Molecular Weight | 401.458 |
| Formula | C24H23N3O3 |
| Cas No. | 956783-34-9 |
| Smiles | O=C1NC(C(=O)N1CC(=O)C=2C=3C=CC=CC3N(C2C=4C=CC=CC4)C)(C)C5CC5 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.